NDAOPHTHALMICSOLUTION/DROPS
Approved
Jul 2009
Lifecycle
Peak
Competitive Pressure
8/100
Mechanism of Action
anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis.
Indications (2)
Loss of Exclusivity
LOE Date
Aug 15, 2029
42 months away
Patent Expiry
Aug 15, 2029